My Beauty and Care Ltd 30/09/2021 iXBRL


5 30/09/2021 2021-09-30 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2020-10-01 Sage Accounts Production 2020 Update 1 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 08697128 2020-10-01 2021-09-30 08697128 2021-09-30 08697128 2020-09-30 08697128 2019-10-01 2020-09-30 08697128 2020-09-30 08697128 core:PlantMachinery 2020-10-01 2021-09-30 08697128 core:FurnitureFittingsToolsEquipment 2020-10-01 2021-09-30 08697128 core:MotorVehicles 2020-10-01 2021-09-30 08697128 bus:RegisteredOffice 2020-10-01 2021-09-30 08697128 bus:OrdinaryShareClass1 2020-10-01 2021-09-30 08697128 bus:OrdinaryShareClass2 2020-10-01 2021-09-30 08697128 bus:OrdinaryShareClass3 2020-10-01 2021-09-30 08697128 bus:Director1 2020-10-01 2021-09-30 08697128 core:WithinOneYear 2021-09-30 08697128 core:WithinOneYear 2020-09-30 08697128 core:ShareCapital 2021-09-30 08697128 core:ShareCapital 2020-09-30 08697128 core:RetainedEarningsAccumulatedLosses 2021-09-30 08697128 core:RetainedEarningsAccumulatedLosses 2020-09-30 08697128 bus:OrdinaryShareClass1 core:ShareCapital 2021-09-30 08697128 bus:OrdinaryShareClass1 core:ShareCapital 2020-09-30 08697128 bus:OrdinaryShareClass2 core:ShareCapital 2021-09-30 08697128 bus:OrdinaryShareClass2 core:ShareCapital 2020-09-30 08697128 bus:OrdinaryShareClass3 core:ShareCapital 2021-09-30 08697128 bus:OrdinaryShareClass3 core:ShareCapital 2020-09-30 08697128 bus:SmallEntities 2020-10-01 2021-09-30 08697128 bus:AuditExemptWithAccountantsReport 2020-10-01 2021-09-30 08697128 bus:AbridgedAccounts 2020-10-01 2021-09-30 08697128 bus:SmallCompaniesRegimeForAccounts 2020-10-01 2021-09-30 08697128 bus:PrivateLimitedCompanyLtd 2020-10-01 2021-09-30
Company registration number: 08697128
My Beauty and Care Ltd
Unaudited filleted abridged financial statements
30 September 2021
My Beauty and Care Ltd
Contents
Directors and other information
Abridged statement of financial position
Notes to the financial statements
My Beauty and Care Ltd
Directors and other information
Directors V Gudka
Company number 08697128
Registered office Unit 24 Metro Centre
Dwight Road
Watford
WD18 9SB
Business address Unit 24 Metro Centre
Dwight Road
Watford
WD18 9SB
My Beauty and Care Ltd
Abridged statement of financial position
30 September 2021
2021 2020
Note £ £ £ £
Fixed assets
Tangible assets 5 1,313 1,641
_______ _______
1,313 1,641
Current assets
Stocks 126,514 100,324
Debtors 263,234 89,099
Cash at bank and in hand 351,573 403,450
_______ _______
741,321 592,873
Creditors: amounts falling due
within one year ( 205,842) ( 193,932)
_______ _______
Net current assets 535,479 398,941
_______ _______
Total assets less current liabilities 536,792 400,582
_______ _______
Net assets 536,792 400,582
_______ _______
Capital and reserves
Called up share capital 6 1,280 1,280
Profit and loss account 535,512 399,302
_______ _______
Shareholders funds 536,792 400,582
_______ _______
For the year ending 30 September 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 30 September 2021 in accordance with Section 444(2A) of the Companies Act 2006.
These financial statements were approved by the board of directors and authorised for issue on 27 October 2022 , and are signed on behalf of the board by:
V Gudka
Director
Company registration number: 08697128
My Beauty and Care Ltd
Notes to the financial statements
Year ended 30 September 2021
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 24 Metro Centre, Dwight Road, Watford, WD18 9SB.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The Triennial review 2017 amendments to the standard have been early adopted.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
At the time of approving the financial statements, the director has reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The director has also considered the consequences of Covid-19 and other events and conditions and COVID-19 is not expected to have a significant impact on the entity. The director has determined that there is no material uncertainty that casts doubt on the entity's ability to continue as a going concern. It is expected that Covid-19 might have some impact, though not significant that will require any adjustment or disclosure in these accounts. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery - 15 % reducing balance
Fittings fixtures and equipment - 20 % reducing balance
Motor vehicles - 25 % straight line
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received.Government grants are recognised using the accrual model and the performance model.Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset.Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.The company has received government grants under the Covid-19 Job Retention Scheme. The company has also received council grant under during the period.For the monthly Job Retention Scheme, the income has been recognised in the period to which the underlying furloughed staff costs relate to. In recognising the grant income, the company has adopted the accounting policy under FRS102 in accordance to paragraph 24.4 for both grants. There is no contingencies attached to these grants and have been recognised as other operating income in the profit and loss account.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 5 (2020: 5 ).
5. Tangible assets
£
Cost
At 1 October 2020 and 30 September 2021 5,427
_______
Depreciation
At 1 October 2020 3,786
Charge for the year 328
_______
At 30 September 2021 4,114
_______
Carrying amount
At 30 September 2021 1,313
_______
At 30 September 2020 1,641
_______
6. Called up share capital
Issued, called up and fully paid
2021 2020
No £ No £
Ordinary shares of £ 1.00 each 1,000 1,000 1,000 1,000
Ordinary B shares of £ 1.00 each 180 180 180 180
Ordinary C shares of £ 1.00 each 100 100 100 100
_______ _______ _______ _______
1,280 1,280 1,280 1,280
_______ _______ _______ _______
7. Controlling party
During the year the company was controlled by V Gudka who is a director and shareholder of the company.